143 related articles for article (PubMed ID: 38273849)
61. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
62. Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Tang M; Zhou Q; Huang M; Sun K; Wu T; Li X; Liao B; Chen L; Liao J; Peng S; Chen S; Feng ST
Eur Radiol; 2021 Nov; 31(11):8615-8627. PubMed ID: 33877387
[TBL] [Abstract][Full Text] [Related]
63. Prediction of sorafenib treatment-related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation.
Dong Z; Huang K; Liao B; Cai H; Dong Y; Huang M; Zhou X; Jia Y; Xu L; Luo Y; Li ZP; Feng ST
Eur Radiol; 2019 May; 29(5):2272-2282. PubMed ID: 30547202
[TBL] [Abstract][Full Text] [Related]
64. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
[TBL] [Abstract][Full Text] [Related]
65. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract][Full Text] [Related]
66. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
67. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
68. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
69. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.
Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ
Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273
[TBL] [Abstract][Full Text] [Related]
70. Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.
Zhang J; Wu Z; Zhao J; Liu S; Zhang X; Yuan F; Shi Y; Song B
Eur Radiol; 2021 Jun; 31(6):3661-3672. PubMed ID: 33245493
[TBL] [Abstract][Full Text] [Related]
71. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
[TBL] [Abstract][Full Text] [Related]
72. Predictive effects of preoperative serum CA125 and AFP levels on post-hepatectomy survival in patients with hepatitis B-related hepatocellular carcinoma.
Qin C; Gao Y; Li J; Huang C; He S
Oncol Lett; 2021 Jun; 21(6):487. PubMed ID: 33968203
[TBL] [Abstract][Full Text] [Related]
73. Extracellular volume fraction using contrast-enhanced CT is useful in differentiating intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma.
Honda T; Onishi H; Fukui H; Yano K; Kiso K; Nakamoto A; Tsuboyama T; Ota T; Tatsumi M; Tahara S; Kobayashi S; Eguchi H; Tomiyama N
Front Oncol; 2023; 13():1214977. PubMed ID: 37483497
[TBL] [Abstract][Full Text] [Related]
74. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
[TBL] [Abstract][Full Text] [Related]
75. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
[TBL] [Abstract][Full Text] [Related]
76. Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.
Park SH; Lee SS; Yu E; Kang HJ; Park Y; Kim SY; Lee SJ; Shin YM; Lee MG
J Magn Reson Imaging; 2017 Jul; 46(1):267-280. PubMed ID: 27875000
[TBL] [Abstract][Full Text] [Related]
77. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Zhou XD; Tang ZY; Fan J; Zhou J; Wu ZQ; Qin LX; Ma ZC; Sun HC; Qiu SJ; Yu Y; Ren N; Ye QH; Wang L; Ye SL
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1073-80. PubMed ID: 19294418
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.
Tao LY; He XD; Xiu DR
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):682-687. PubMed ID: 27282820
[TBL] [Abstract][Full Text] [Related]
79. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
80. Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors.
Park SH; Heo S; Kim B; Lee J; Choi HJ; Sung PS; Choi JI
Korean J Radiol; 2023 Mar; 24(3):190-203. PubMed ID: 36788766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
